Yifang Gao1, Sarita Workman2, Stephan Gadola3, Tim Elliott1, Bodo Grimbacher2, Anthony P Williams4. 1. Faculty of Medicine, Cancer Sciences Division, University of Southampton, Southampton, United Kingdom. 2. Department of Clinical Immunology and Molecular Pathology, Royal Free Hospital, London, United Kingdom; University College London, London, United Kingdom. 3. Faculty of Medicine, Clinical and Experimental Sciences Division, University of Southampton, Southampton, United Kingdom. 4. Faculty of Medicine, Cancer Sciences Division, University of Southampton, Southampton, United Kingdom. Electronic address: apw2@soton.ac.uk.
Abstract
BACKGROUND: Common variable immunodeficiency (CVID) is the commonest symptomatic primary antibody disorder, with monogenic causes identified in less than 10% of all cases. X-linked proliferative disease is a monogenic disorder that is associated with hypogammaglobulinemia and characterized by a deficiency of invariant NKT (iNKT) cells. We sought to evaluate whether a defect in iNKT cell number or function was associated with CVID. OBJECTIVE: An evaluation of the function and number of iNKT cells in CVID. METHODS: Six-color flow cytometry enumerated iNKT cells in 36 patients with CVID and 50 healthy controls. Their proliferative capacity and cytokine production (IFN-γ, IL-13, IL-17) was then investigated following activation with CD1d ligand alpha-galactosylceramide. RESULTS: A reduction in the number of iNKT cells (31 iNKT cells/10(5) T cells) in patients with CVID compared with healthy controls (100 iNKT cells/10(5) T cells) was observed (P < .0001). Two cohorts could be discerned within the CVID group: group 1 with an abnormal number of iNKT cells (n = 28) and group 2 with a normal number of iNKT cells (n = 8). This segregation coassociated with the proliferative capacity of iNKT cells between the 2 groups. However, differences in the function of iNKT cells were noted in group 2, in which an increase in IFN-γ (P = .0016) and a decrease in IL-17 (P = .0002) production was observed between patients with CVID and controls. Finally, a significant association was seen between the number of iNKT cells and the percentage of class-switched memory B cells and propensity to lymphoproliferation (P = .002) in patients with CVID. CONCLUSION: iNKT cells are deficient and/or functionally impaired in most of the patients with CVID.
BACKGROUND: Common variable immunodeficiency (CVID) is the commonest symptomatic primary antibody disorder, with monogenic causes identified in less than 10% of all cases. X-linked proliferative disease is a monogenic disorder that is associated with hypogammaglobulinemia and characterized by a deficiency of invariant NKT (iNKT) cells. We sought to evaluate whether a defect in iNKT cell number or function was associated with CVID. OBJECTIVE: An evaluation of the function and number of iNKT cells in CVID. METHODS: Six-color flow cytometry enumerated iNKT cells in 36 patients with CVID and 50 healthy controls. Their proliferative capacity and cytokine production (IFN-γ, IL-13, IL-17) was then investigated following activation with CD1d ligand alpha-galactosylceramide. RESULTS: A reduction in the number of iNKT cells (31 iNKT cells/10(5) T cells) in patients with CVID compared with healthy controls (100 iNKT cells/10(5) T cells) was observed (P < .0001). Two cohorts could be discerned within the CVID group: group 1 with an abnormal number of iNKT cells (n = 28) and group 2 with a normal number of iNKT cells (n = 8). This segregation coassociated with the proliferative capacity of iNKT cells between the 2 groups. However, differences in the function of iNKT cells were noted in group 2, in which an increase in IFN-γ (P = .0016) and a decrease in IL-17 (P = .0002) production was observed between patients with CVID and controls. Finally, a significant association was seen between the number of iNKT cells and the percentage of class-switched memory B cells and propensity to lymphoproliferation (P = .002) in patients with CVID. CONCLUSION: iNKT cells are deficient and/or functionally impaired in most of the patients with CVID.
Authors: Javier Rodríguez-Ubreva; Anna Arutyunyan; Marc Jan Bonder; Lucía Del Pino-Molina; Stephen J Clark; Carlos de la Calle-Fabregat; Luz Garcia-Alonso; Louis-François Handfield; Laura Ciudad; Eduardo Andrés-León; Felix Krueger; Francesc Català-Moll; Virginia C Rodríguez-Cortez; Krzysztof Polanski; Lira Mamanova; Stijn van Dongen; Vladimir Yu Kiselev; María T Martínez-Saavedra; Holger Heyn; Javier Martín; Klaus Warnatz; Eduardo López-Granados; Carlos Rodríguez-Gallego; Oliver Stegle; Gavin Kelsey; Roser Vento-Tormo; Esteban Ballestar Journal: Nat Commun Date: 2022-04-01 Impact factor: 17.694
Authors: Gabriel K Wong; David Millar; Sarah Penny; James M Heather; Punam Mistry; Nico Buettner; Jane Bryon; Aarnoud P Huissoon; Mark Cobbold Journal: J Immunol Date: 2016-08-01 Impact factor: 5.422